CELLFX
Pulse Biosciences, Inc.
>Mark For: CELLFX® trademark registration is intended to cover the following codes and category IC 044. US 100 101. G & S: Oncology, immunology and dermatology services using electric pulse technology; cosmetic medical services, namely, services for tissuemanipulation and modification; providing information in the field of oncology and medical and cosmetic tissue modification, manipulationand/or ablation using electric pulse technology; immunotherapeutic services for treating medical conditions; medical assistance servicesprovided through use of short electric pulses, including nanopulse electricity, for human and animal biomedical applications, including for theprevention, detection, diagnosis and treatment of medical conditions, diseases and injuries; medical assistance services through use ofnanopulse technology for ablation, manipulation or modification of biologic tissue; medical assistance services, namely, use of electric pulsetechnology for treatment of tumors, tissue growth, skin growth, warts, papilloma, and other medical conditions and disease, all of whichexclude services related to treatment of cellulite. FIRST USE: 20210212. FIRST USE IN COMMERCE: 20210212.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87748866 |
| Registration Number | 6348388 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Mark Type | SERVICE MARK |
| Register | PRINCIPAL |
| Attorney Name | Lena Vinitskaya |
| Attorney Docket Number | TM_01B |
| Law Office Assigned | M80 |
| Employee Name | BLANDU, FLORENTINA |
Timeline
| 2018-01-09 | Application Filed |
| 2018-09-11 | Published for Opposition |
| 2018-10-09 | Status: Live/Pending |
| 2019-02-05 | Location: PETITIONS OFFICE |
| 2019-02-06 | Transaction Date |
| 2021-05-11 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Pulse Biosciences, Inc. |
| Address | 3957 Point Eden Way Hayward NV 94545 |
| Legal Entity Type | Corporation |
| Legal Entity State | NV |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
IC 044. US 100 101. G & S: Oncology, immunology and dermatology services using electric pulse technology; cosmetic medical services, namely, services for tissuemanipulation and modification; providing information in the field of oncology and medical and cosmetic tissue modification, manipulationand/or ablation using electric pulse technology; immunotherapeutic services for treating medical conditions; medical assistance servicesprovided through use of short electric pulses, including nanopulse electricity, for human and animal biomedical applications, including for theprevention, detection, diagnosis and treatment of medical conditions, diseases and injuries; medical assistance services through use ofnanopulse technology for ablation, manipulation or modification of biologic tissue; medical assistance services, namely, use of electric pulsetechnology for treatment of tumors, tissue growth, skin growth, warts, papilloma, and other medical conditions and disease, all of whichexclude services related to treatment of cellulite. FIRST USE: 20210212. FIRST USE IN COMMERCE: 20210212
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0101 | Medical apparatus and devices for treatment in the nature of pulsed electrical destruction or reduction of benign and non-benign biological tissues; medical devices using pulsed electricity for use in treating skin growth, skin lesions and skin conditions; medical devices, namely, medical pulse generators and pulse generator circuits for tissue modification, manipulation and/or ablation; medical apparatus designed for use with nanopulse electricity for manipulation, modification and/or ablation of biologic tissue; medical apparatus, devices and instruments utilizing electrical pulsing technology for prevention, detection, diagnosis and treatment of medical disease, injuries and conditions, namely, tumors, skin and tissue disorders, warts, viruses, papillomas, and other tissue and skin growths; medical systems comprising medical devices in the nature of pulse generators, pulse generator circuits, medical probes, medical wands, medical electrodes and microneedle treatment tips for use in tissue modification, manipulation and /or ablation; medical and surgical devices, and medical systems and accessories comprised of skin marking tools, guides for placement of medical electrodes on lesions or tumors all for diagnosis and treatment of tissue and blood diseases, conditions and abnormalities; medical pulse generators and medical electrodes for nanosecond pulse delivery for treatment of medical conditions or cosmetic tissue defects; medical device accessories to enable treatment of biological tissues, namely, microneedle treatment tips, medical electrodes, electric medical connectors, medical handpieces, medical probes to access internal and external anatomical areas and coupling gels sold as a unit, and tissue marking tools; all of which exclude apparatus and devices for the treatment of cellulite |
| GS0441 | Oncology, immunology and dermatology services using electric pulse technology; cosmetic medical services, namely, services for tissuemanipulation and modification; providing information in the field of oncology and medical and cosmetic tissue modification, manipulationand/or ablation using electric pulse technology; immunotherapeutic services for treating medical conditions; medical assistance servicesprovided through use of short electric pulses, including nanopulse electricity, for human and animal biomedical applications, including for theprevention, detection, diagnosis and treatment of medical conditions, diseases and injuries; medical assistance services through use ofnanopulse technology for ablation, manipulation or modification of biologic tissue; medical assistance services, namely, use of electric pulsetechnology for treatment of tumors, tissue growth, skin growth, warts, papilloma, and other medical conditions and disease, all of whichexclude services related to treatment of cellulite |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2018-01-12 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-01-23 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-04-18 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-04-23 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2018-04-23 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-04-23 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-06-13 | 7 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2018-06-28 | 8 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-07-02 | 9 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-07-02 | 10 TEME I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-07-09 | 11 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-08-09 | 12 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-08-22 | 13 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-09-11 | 14 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-09-11 | 15 NPUB E:E-Mail |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2018-10-09 | 16 ETOF T:TTAB Proceeding |
| TEAS POST PUBLICATION AMENDMENT RECEIVED | 2019-01-23 | 17 EPPA I:Incoming Correspondence |
| ASSIGNED TO PETITION STAFF | 2019-02-01 | 18 APET A:Allowance for Publication |
| CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | 2019-02-04 | 19 CHPB I:Incoming Correspondence |
| EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 2019-02-13 | 20 ETOP T:TTAB Proceeding |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-03-26 | 21 NOAM E:E-Mail |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2019-07-24 | 22 ASGN I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2019-08-29 | 23 EEXT I:Incoming Correspondence |
| TEAS REQUEST TO DIVIDE RECEIVED | 2019-08-29 | 24 ERTD I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-09-04 | 25 AITU A:Allowance for Publication |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-09-05 | 26 AITU A:Allowance for Publication |
| DIVISIONAL REQUEST RECEIVED | 2019-08-29 | 27 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2019-10-09 | 28 DPCC D:Assigned to Examiner |
| EXTENSION 1 FILED | 2019-08-29 | 29 EXT1 S: |
| EXTENSION 1 GRANTED | 2019-10-09 | 30 EX1G S: |
| CORRECTED NOA E-MAILED | 2019-10-10 | 31 NOAC E:E-Mail |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-10-10 | 32 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2020-03-17 | 33 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2020-03-17 | 34 EXT2 S: |
| EXTENSION 2 GRANTED | 2020-03-17 | 35 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-03-19 | 36 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2020-09-12 | 37 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2020-09-12 | 38 EXT3 S: |
| EXTENSION 3 GRANTED | 2020-09-12 | 39 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-09-15 | 40 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2021-03-18 | 41 EISU I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2021-03-18 | 42 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2021-03-18 | 43 EXT4 S: |
| EXTENSION 4 GRANTED | 2021-03-24 | 44 EX4G S: |
| USE AMENDMENT FILED | 2021-03-18 | 45 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2021-03-24 | 46 SUPC I:Incoming Correspondence |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-03-25 | 47 EXRA E:E-Mail |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2021-04-07 | 48 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2021-04-08 | 49 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2021-05-11 | 50 R.PR A:Allowance for Publication |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 